Hydronephrosis and risk of later development of hypertension
- PMID: 29959876
- DOI: 10.1111/apa.14482
Hydronephrosis and risk of later development of hypertension
Abstract
Aim: Congenital ureteral obstruction is a fairly common condition in infants, and its clinical management has been long debated during the last decade. The long-term physiological consequences of today's conservative non-surgical management in many asymptomatic hydronephrotic children are unclear.
Methods: Experimental studies in rats and mice, retrospective studies in children and adults, as well as prospective studies in children are included in this mini review.
Results: Experimental models of hydronephrosis in rats and mice have demonstrated that partial ureteropelvic junction obstruction (UPJO) is casually linked with development of hypertension and renal injuries in later life. The mechanisms are multifactorial and involve increased activity of the renin-angiotensin-aldosterone system and renal sympathetic nerve activity. Furthermore, oxidative stress and nitric oxide deficiency in the affected kidney appear to play important roles in the development and maintenance of hypertension. Clinical case reports in adults and recent prospective studies in children have associated hydronephrosis with elevated blood pressure, which could be reduced by surgical management of the obstruction.
Conclusion: Based on current experimental and clinical knowledge regarding the link between partial UPJO and changes in blood pressure, it is proposed that today's non-operative management of hydronephrosis should be reconsidered to reduce the risk of developing elevated blood pressure or hypertension in later life.
Keywords: Blood pressure; Hydronephrosis; Hypertension; Ureteral obstruction.
©2018 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Similar articles
-
Causal link between neonatal hydronephrosis and later development of hypertension.Clin Exp Pharmacol Physiol. 2010 Feb;37(2):e14-23. doi: 10.1111/j.1440-1681.2009.05267.x. Epub 2009 Aug 4. Clin Exp Pharmacol Physiol. 2010. PMID: 19671072 Review.
-
Surgical treatment reduces blood pressure in children with unilateral congenital hydronephrosis.J Pediatr Urol. 2015 Apr;11(2):91.e1-6. doi: 10.1016/j.jpurol.2015.01.008. Epub 2015 Mar 11. J Pediatr Urol. 2015. PMID: 25819380
-
Hydronephrosis is associated with elevated plasmin in urine in pediatric patients and rats and changes in NCC and γ-ENaC abundance in rat kidney.Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F547-F557. doi: 10.1152/ajprenal.00635.2017. Epub 2018 May 16. Am J Physiol Renal Physiol. 2018. PMID: 29767556
-
Hydronephrosis causes salt-sensitive hypertension in rats.J Hypertens. 2006 Jul;24(7):1437-43. doi: 10.1097/01.hjh.0000234126.78766.00. J Hypertens. 2006. PMID: 16794495
-
Urinary biomarkers in hydronephrosis.Dan Med J. 2013 Feb;60(2):B4582. Dan Med J. 2013. PMID: 23461995 Review.
Cited by
-
Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy versus retrograde ureteral stenting in the treatment of acute obstructive upper urinary tract infection.Ther Adv Urol. 2024 Apr 12;16:17562872241241854. doi: 10.1177/17562872241241854. eCollection 2024 Jan-Dec. Ther Adv Urol. 2024. PMID: 38618182 Free PMC article.
-
Use of double-J ureteric stents post-laparoscopic pyeloplasty to treat ureteropelvic junction obstruction in hydronephrosis for pediatric patients: a single-center experience.J Int Med Res. 2020 Apr;48(4):300060520918781. doi: 10.1177/0300060520918781. J Int Med Res. 2020. PMID: 32345075 Free PMC article.
-
A 37-year-old male with unilateral hydronephrosis: A forgotten cause of secondary hypertension.J Family Med Prim Care. 2020 Feb 28;9(2):1219-1221. doi: 10.4103/jfmpc.jfmpc_1136_19. eCollection 2020 Feb. J Family Med Prim Care. 2020. PMID: 32318499 Free PMC article.
-
Sudden-onset hypertension leading to the diagnosis of unilateral hydronephrosis due to ureteropelvic junction obstruction.CEN Case Rep. 2024 Aug;13(4):243-248. doi: 10.1007/s13730-023-00832-4. Epub 2023 Nov 28. CEN Case Rep. 2024. PMID: 38015311 Free PMC article.
-
Novel multifunctional targeted nanozyme as an ultrasound contrast agent for real-time monitoring and treatment of congenital hydronephrosis renal fibrosis.J Nanobiotechnology. 2025 Aug 6;23(1):553. doi: 10.1186/s12951-025-03618-1. J Nanobiotechnology. 2025. PMID: 40770726 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical